Evotec (ETR:EVT) Trading 0.3% Higher – What’s Next?

Evotec SE (ETR:EVT)’s share price was up 0.3% during mid-day trading on Tuesday . The stock traded as high as €10.50 ($11.17) and last traded at €10.50 ($11.17). Approximately 2,505,337 shares traded hands during trading, an increase of 84% from the average daily volume of 1,360,000 shares. The stock had previously closed at €10.47 ($11.14).

Evotec Stock Up 0.3 %

The stock’s 50-day simple moving average is €6.61 and its 200-day simple moving average is €7.72. The firm has a market capitalization of $1.86 billion, a P/E ratio of -10.94, a P/E/G ratio of 0.98 and a beta of 1.05. The company has a current ratio of 1.83, a quick ratio of 2.97 and a debt-to-equity ratio of 46.81.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.